TH2 cytokine levels rise in AC-bearing mice and human NSCLC patients, and alternative activation resulting from TH2-like cytokines increases IGF-1 macrophage production [11,38,39,44]. This evidence concerns the gene IGF1 and non-small cell lung carcinoma.